Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): a multicentre, open-label, single-arm, phase 2 study

Authors: Zinzani, Pier Luigi ^{a, *}, Izutsu, Koji ^b, Mehta-Shah, Neha ^c, Barta, Stefan K ^d, Ishitsuka, Kenji ^e, Córdoba, Raul ^f, Kusumoto, Shigeru ^g, Bachy, Emmanuel ^h, Cwynarski, Kate ⁱ, Gritti, Giuseppe ^j, Prica, Anca ^k, Jacobsen, Eric ^l, Feldman, Tatyana ^m, Guillermin, Yann ⁿ, Ennishi, Daisuke ^o, Yoon, Dok Hyun ^p, Domenech, Eva Domingo ^q, Zain, Jasmine ^r, Wang, Jie ^s, Kim, Jin Seok ^t, Poel, Marjolein van der ^u, Jin, Jin ^v, Wu, Sutan ^v, Chen, Yang ^v, Moriyama, Takaya ^v, Inoue, Ai ^v, Nakajima, Keiko ^v, Horwitz, Steven M ^w

Source: In The Lancet Oncology December 2024 25(12):1602-1613

Valemetostat monotherapy in patients with relapsed or refractory non-Hodgkin lymphoma: a first-in-human, multicentre, open-label, single-arm, phase 1 study

Authors: Maruyama, Dai ^{a, b, *}, Jacobsen, Eric ^c, Porcu, Pierluigi ^d, Allen, Pamela ^e, Ishitsuka, Kenji ^f, Kusumoto, Shigeru ^g, Narita, Tomoko ^g, Tobinai, Kensei ^a, Foss, Francine ^h, Tsukasaki, Kunihiro ⁱ, Feldman, Tatyana ^j, Imaizumi, Yoshitaka ^{k, l}, Izutsu, Koji ^a, Morishima, Satoko ^m, Yamauchi, Nobuhiko ⁿ, Yuda, Junichiro ⁿ, Brammer, Jonathan E ^o, Kawamata, Toyotaka ^{p, q}, Ruan, Jia ^r, Nosaka, Kisato ^s, Utsunomiya, Atae ^t, Wang, Jie ^u, Zain, Jasmine ^v, Kakurai, Yasuyuki ^w, Yamauchi, Hideyuki ^w, Hizukuri, Yoshiyuki ^x, Biserna, Noha ^x, Tachibana, Masaya ^w, Inoue, Ai ^x, Horwitz, Steven M ^y

Source: In The Lancet Oncology December 2024 25(12):1589-1601

Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in patients with B-cell malignancies: analysis of the Richter transformation subgroup from the multicentre, open-label, phase 1/2 BRUIN study

Authors: Wierda, William G ^*, Shah, Nirav N, Cheah, Chan Y, Lewis, David, Hoffmann, Marc S, Coombs, Catherine C, Lamanna, Nicole, Ma, Shuo, Jagadeesh, Deepa, Munir, Talha, Wang, Yucai, Eyre, Toby A, Rhodes, Joanna M, McKinney, Matthew, Lech-Maranda, Ewa, Tam, Constantine S, Jurczak, Wojciech, Izutsu, Koji, Alencar, Alvaro J, Patel, Manish R, Seymour, John F, Woyach, Jennifer A, Thompson, Philip A, Abada, Paolo B, Ho, Caleb, McNeely, Samuel C, Marella, Narasimha, Nguyen, Bastien, Wang, Chunxiao, Ruppert, Amy S, Nair, Binoj, Liu, Hui, Tsai, Donald E, Roeker, Lindsey E, Ghia, Paolo

Source: In The Lancet Haematology September 2024 11(9):e682-e692

Heterogeneity or change in cell of origin in diffuse large B-cell lymphomas determined using hans algorithm

Authors: Maeshima, Akiko Miyagi, Taniguchi, Hirokazu, Takahashi, Yuka, Kaimi, Yuto, Ochi, Tetsuro, Makino, Haruhi, Makita, Shinichi, Iwaki, Noriko, Fukuhara, Suguru, Munakata, Wataru, Izutsu, Koji

Source: In Human Pathology September 2024 151

Clinicopathological differences between T-lymphoblastic leukemia/lymphoma, early T-precursor lymphoblastic leukemia/lymphoma, and mixed-phenotype acute leukemia with T lineage: An analysis of 41 adult cases

Authors: Takahashi, Yuka, Kaimi, Yuto, Taniguchi, Hirokazu, Ochi, Tetsuro, Makino, Haruhi, Makita, Shinichi, Iwaki, Noriko, Fukuhara, Suguru, Munakata, Wataru, Izutsu, Koji, Maeshima, Akiko Miyagi

Source: In Human Pathology August 2024 150:78-85

Diagnostic clues of BCL2-negative, faint, or controversial follicular lymphomas: a study of 103 cases

Authors: Maeshima, Akiko Miyagi, Taniguchi, Hirokazu, Furukawa, Haruhi, Hattori, Daiki, Sasaki, Hirokazu, Makita, Shinichi, Iwaki, Noriko, Fukuhara, Suguru, Munakata, Wataru, Izutsu, Koji

Source: Human pathology. 135:84-92

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100187592066.0x000001&indx=1&recIds=ETOCvdc_100187592066.0x000001

Clinical utility of genomic profiling of AML using paraffin‐embedded bone marrow clots: HM‐SCREEN‐Japan 01

Authors: Hosono, Naoko, Chi, SungGi, Yamauchi, Takahiro, Fukushima, Kentaro, Shibayama, Hirohiko, Katagiri, Seiichiro, Gotoh, Akihiko, Eguchi, Motoki, Morishita, Takanobu, Ogasawara, Reiki, Kondo, Takeshi, Yanada, Masamitsu, Yamamoto, Kazuhito, Kobayashi, Tsutomu, Kuroda, Junya, Usuki, Kensuke, Utsu, Yoshikazu, Yoshimitsu, Makoto, Ishitsuka, Kenji, Ono, Takaaki, Takahashi, Naoto, Iyama, Satoshi, Kojima, Kensuke, Nakamura, Yukinori, Fukuhara, Suguru, Izutsu, Koji, Abutani, Hikaru, Yamauchi, Nobuhiko, Yuda, Junichiro, Minami, Yosuke

Source: Cancer science. 114(5):2098-2108

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100181645741.0x000001&indx=1&recIds=ETOCvdc_100181645741.0x000001

Darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: results of an Asian phase 2 study

Authors: Kim, Won-Seog, Fukuhara, Noriko, Yoon, Dok-Hyun, Yamamoto, Kazuhito, Uchida, Toshiki, Negoro, Eiju, Izutsu, Koji, Terui, Yasuhito, Nakajima, Hideaki, Ando, Kiyoshi, Suehiro, Youko, Kang, Hye Jin, Ko, Po-Shen, Nagahama, Fumiko, Sonehara, Yusuke, Nagai, Hirokazu, Tien, Hwei-Fang, Kwong, Yok-Lam, Tobinai, Kensei

Source: In Blood Advances 12 September 2023 7(17):4903-4912

Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial

Authors: Song, Yuqin, Tilly, Hervé, Rai, Shinya, Zhang, Huilai, Jin, Jie, Goto, Hideki, Terui, Yasuhito, Shin, Ho-Jin, Kim, Won Seog, Cao, Junning, Feng, Jifeng, Eom, Hyeon Seok, Kim, Tae Min, Tsai, Xavier Cheng-Hong, Gau, Jyh-Pyng, Koh, Hideo, Zhang, Liling, Song, Yongping, Yang, Yu, Li, Wei, Huang, He, Ando, Kiyoshi, Sharman, Jeff P., Sehn, Laurie H., Bu, Lilian, Wang, Xin, Jiang, Yanwen, Hirata, Jamie, Lee, Calvin, Zhu, Jun, Izutsu, Koji

Source: In Blood 20 April 2023 141(16):1971-1981

Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study

Authors: Abramson, Jeremy S. ^∗, Solomon, Scott R., Arnason, Jon, Johnston, Patrick B., Glass, Bertram, Bachanova, Veronika, Ibrahimi, Sami, Mielke, Stephan, Mutsaers, Pim, Hernandez-Ilizaliturri, Francisco, Izutsu, Koji, Morschhauser, Franck, Lunning, Matthew, Crotta, Alessandro, Montheard, Sandrine, Previtali, Alessandro, Ogasawara, Ken, Kamdar, Manali

Source: In Blood 6 April 2023 141(14):1675-1684

An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma

Authors: Izutsu, Koji, Makita, Shinichi, Nosaka, Kisato, Yoshimitsu, Makoto, Utsunomiya, Atae, Kusumoto, Shigeru, Morishima, Satoko, Tsukasaki, Kunihiro, Kawamata, Toyotaka, Ono, Takaaki, Rai, Shinya, Katsuya, Hiroo, Ishikawa, Jun, Yamada, Hironori, Kato, Kazunobu, Tachibana, Masaya, Kakurai, Yasuyuki, Adachi, Nobuaki, Tobinai, Kensei, Yonekura, Kentaro, Ishitsuka, Kenji

Source: In Blood 9 March 2023 141(10):1159-1168

Health-related quality of life with lisocabtagene maraleucel vs standard of care in relapsed or refractory LBCL

Authors: Abramson, Jeremy S. ^∗, Johnston, Patrick B., Kamdar, Manali, Ibrahimi, Sami, Izutsu, Koji, Arnason, Jon, Glass, Bertram, Mutsaers, Pim, Lunning, Matthew, Braverman, Julia, Liu, Fei Fei, Crotta, Alessandro, Montheard, Sandrine, Previtali, Alessandro, Guo, Shien, Shi, Ling, Solomon, Scott R.

Source: In Blood Advances 13 December 2022 6(23):5969-5979

Five‐year follow‐up of a phase II study of DA‐EPOCH‐R with high‐dose MTX in CD5‐positive DLBCL

Authors: Miyazaki, Kana, Sakai, Rika, Iwaki, Noriko, Yamamoto, Go, Murayama, Kayoko, Nishikori, Momoko, Sunami, Kazutaka, Yoshida, Isao, Yano, Hiroki, Takahashi, Naoki, Okamoto, Akinao, Munemoto, Saori, Sawazaki, Aiko, Suehiro, Youko, Fukuhara, Noriko, Wake, Atsushi, Arai, Ayako, Masaki, Yasufumi, Toyama, Kohtaro, Yokoyama, Akihiro, Tsunemine, Hiroko, Hasegawa, Yuichi, Matsumoto, Kenji, Yamada, Tomomi, Nishimura, Yuki, Tamaru, Satoshi, Asano, Naoko, Miyawaki, Kohta, Izutsu, Koji, Kinoshita, Tomohiro, Suzuki, Ritsuro, Ohshima, Koichi, Kato, Koji, Katayama, Naoyuki, Yamaguchi, Motoko

Source: Cancer science. 114(6):2689-2691

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100192113234.0x000001&indx=1&recIds=ETOCvdc_100192113234.0x000001

Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab (R2) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma

Authors: Morschhauser, Franck, Nastoupil, Loretta, Feugier, Pierre, Schiano de Colella, Jean-Marc, Tilly, Hervé, Palomba, Maria Lia, Bachy, Emmanuel, Fruchart, Christophe, Libby, Edward N., Casasnovas, Rene-Olivier, Flinn, Ian W., Haioun, Corinne, Maisonneuve, Hervé, Ysebaert, Loic, Bartlett, Nancy L., Bouabdallah, Kamal, Brice, Pauline, Ribrag, Vincent, Le Gouill, Steven, Daguindau, Nicolas, Guidez, Stéphanie, Pica, Gian Matteo, García-Sancho, Alejandro Martín, López-Guillermo, Armondo, Larouche, Jean-François, Ando, Kiyoshi, Gomes da Silva, Maria, André, Marc, Kalung, Wu, Sehn, Laurie H., Izutsu, Koji, Cartron, Guillaume, Gkasiamis, Argyrios, Crowe, Russell, Xerri, Luc, Fowler, Nathan H., Salles, Gilles

Source: Journal of clinical oncology. 40(28):3239-3245

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100172812698.0x000001&indx=1&recIds=ETOCvdc_100172812698.0x000001

Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial

Authors: Kamdar, Manali, Solomon, Scott R, Arnason, Jon, Johnston, Patrick B, Glass, Bertram, Bachanova, Veronika, Ibrahimi, Sami, Mielke, Stephan, Mutsaers, Pim, Hernandez-Ilizaliturri, Francisco, Izutsu, Koji, Morschhauser, Franck, Lunning, Matthew, Maloney, David G, Crotta, Alessandro, Montheard, Sandrine, Previtali, Alessandro, Stepan, Lara, Ogasawara, Ken, Mack, Timothy, Abramson, Jeremy S

Source: Lancet. 399(10343):2294-2308

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100168989425.0x000001&indx=1&recIds=ETOCvdc_100168989425.0x000001

Phase 2 results of lisocabtagene maraleucel in Japanese patients with relapsed/refractory aggressive B‐cell non‐Hodgkin lymphoma

Authors: Makita, Shinichi, Yamamoto, Go, Maruyama, Dai, Asano‐Mori, Yuki, Kaji, Daisuke, Ananthakrishnan, Revathi, Ogasawara, Ken, Stepan, Lara, Schusterbauer, Claudia, Rettby, Nils, Hasskarl, Jens, Izutsu, Koji

Source: Cancer medicine. 11(24):4889-4899

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100168740676.0x000001&indx=1&recIds=ETOCvdc_100168740676.0x000001

CD3-and CD20-negative extramedullary non-Hodgkin leukemia/lymphoma: a histopathological study of 118 cases

Authors: Maeshima, Akiko Miyagi, Taniguchi, Hirokazu, Hattori, Daiki, Sasaki, Hirokazu, Hori, Yoshikazu, Makita, Shinichi, Iwaki, Noriko, Fukuhara, Suguru, Munakata, Wataru, Suzuki, Tatsuya, Izutsu, Koji

Source: Human pathology. 124:14-23

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100162934422.0x000001&indx=1&recIds=ETOCvdc_100162934422.0x000001

Two‐year outcomes of tirabrutinib monotherapy in Waldenström's macroglobulinemia

Authors: Sekiguchi, Naohiro, Rai, Shinya, Munakata, Wataru, Suzuki, Kenshi, Handa, Hiroshi, Shibayama, Hirohiko, Endo, Tomoyuki, Terui, Yasuhito, Iwaki, Noriko, Fukuhara, Noriko, Tatetsu, Hiro, Iida, Shinsuke, Ishikawa, Takayuki, Iguchi, Daisuke, Izutsu, Koji

Source: Cancer science. 113(6):2085-2096

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100153634654.0x000001&indx=1&recIds=ETOCvdc_100153634654.0x000001

Parsaclisib in Japanese patients with relapsed or refractory B‐cell lymphoma (CITADEL‐111): A phase Ib study

Authors: Fukuhara, Noriko, Suehiro, Youko, Kato, Harumi, Kusumoto, Shigeru, Coronado, Cinthya, Rappold, Erica, Zhao, Wanying, Li, Jia, Gilmartin, Aidan, Izutsu, Koji

Source: Cancer science. 113(5):1702-1711

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100151213233.0x000001&indx=1&recIds=ETOCvdc_100151213233.0x000001

The outcome of watchful waiting in patients with previously treated follicular lymphoma

Authors: Fujino, Takahiro, Maruyama, Dai, Maeshima, Akiko‐Miyagi, Saito, Yo, Ida, Hanae, Hosoba, Rika, Yuda, Sayako, Makita, Shinichi, Fukuhara, Suguru, Munakata, Wataru, Suzuki, Tatsuya, Kuroda, Junya, Izutsu, Koji

Source: Cancer medicine. 11(10):2106-2116

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100150412191.0x000001&indx=1&recIds=ETOCvdc_100150412191.0x000001